Human Longevity IPO

www.humanlongevity.com

Human Longevity was founded in 2013 by J. Craig Venter, Peter Diamandis, and Robert Hariri. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Human Longevity is a genomics-based health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype, and clinical data. The company's mission is "to extend healthy human life by revolutionizing human health and transforming the practice of medicine." The company has acquired Cypher Genomics and DoctorsForMe. Human Longevity, based in San Diego, has raised $330 million in venture capital funding from investors including Emerging Technology Partners, Threshold, StartUp Health, OS Fund, Illumina Ventures, GE Ventures, Celgene, and Amino Capital. The company has not disclosed recent valuation information, but in 2018 Human Longevity reported a significant drop in valuation, falling from $1.6 billion to $310 million.

Founded2013
Total Funding to Date$49.3MM
Register for Details

For more details on financing and valuation for Human Longevity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Human Longevity Ticker Symbol

Human Longevity does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Human Longevity Stock Price

The stock price for Human Longevity will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Human Longevity

GE Ventures
Draper Fisher Jurvetson
Illumina
Amino Capital
Celgene
Synthetic Genomics
StartUp Health

Human Longevity Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/6/2019 Series A-2 $50.4MM $XXX.XX $XXX.XX
2/16/2017 Series A-1 $300MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Human Longevity in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM